2[20]Azpiroz F.Hypersensitivity in functional gastrointestinal disorders.Gut 2002; 51 Suppl 1:i25-i28
3[21]Tack J,Caenepeel P,Fischler B,Piessevaux H,Janssens J.Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia.Gastroenterology 2001; 121:526-535
4[22]Salet GA,Samsom M,Roelofs JM,van Berge Henegouwen GP,Smout AJ,Akkermans LM.Responses to gastric distension in functional dyspepsia.Gut 1998; 42:823-829
5[23]Fried M,Erlacher U,Schwizer W,Lochner C,Koerfer J,Beglinger C,Jansen JB,Lamers CB,Harder F,Bischof-Delaloye A.Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans.Studies with the cholecystokinin-receptor antagonist loxiglumide.Gastroenterology 1991; 101:503-511
6[24]Lieverse RJ,Jansen JB,Masclee AA,Rovati LC,Lamers CB.Effect of a low dose of intraduodenal fat on satiety in humans:studies using the type A cholecystokinin receptor antagonist loxiglumide.Gut 1994; 35:501-505
7[25]Miaskiewicz SL,Stricker EM,Verbalis JG.Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distention in humans.J Clin Endocrinol Metab 1989; 68:837-843
8[26]Von Korff RV.Properties of mitochondrial monoamine oxidase isolated from rabbit brain and liver.Biokhimiia 1977;42:396-402
9[27]Mesquita MA,Thompson DG,Troncon LE,D'Amato M,Rovati LC,Barlow J.Effect of cholecystokinin-A receptor blockade on lipid-induced gastric relaxation in humans.Am J Physiol 1997; 273:G118-G123
10[28]Bradette M,Pare P,Douville P,Morin A.Visceral perception in health and functional dyspepsia.Crossover study of gastric distension with placebo and domperidone.Dig Dis Sci 1991;36:52-58
